Engineering a nano delivery system targets EphA2 for treating colorectal cancer oxaliplatin resistant
Materials & Design · 2025-12 · 260 · 115016
DOI: 10.1016/j.matdes.2025.115016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials & Design, 2025-12. Verfasst von Zhengshuo Li und 13 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Provincial Natural Science Foundation, Education Department of Hunan Province, Higher Education Discipline Innovation Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Hunan Provincial Natural Science Foundation
- Education Department of Hunan Province
- Higher Education Discipline Innovation Project
- National Natural Science Foundation of China
- Postdoctoral Science Foundation of Central South University
- Xiangya Hospital, Central South University
- Central South University
- China Postdoctoral Science Foundation
Zitieren
APA
Li, Z., Zhang, X., Liu, C., Wu, Y., Wen, Y., Zheng, R., Xu, C., Tian, J., Peng, Q., Zheng, X., Wang, J., Wei, L., Yan, Q., & Ma, J. (2025). Engineering a nano delivery system targets EphA2 for treating colorectal cancer oxaliplatin resistant. Materials & Design, 260, 115016. https://doi.org/10.1016/j.matdes.2025.115016
Vancouver
Li Z, Zhang X, Liu C, Wu Y, Wen Y, Zheng R, et al. Engineering a nano delivery system targets EphA2 for treating colorectal cancer oxaliplatin resistant. Materials & Design. 2025;260:115016. doi:10.1016/j.matdes.2025.115016
BibTeX
@article{Li2025,
author = {Li, Zhengshuo and Zhang, Xiaoyue and Liu, Can and Wu, Yangge and Wen, Yuqing and Zheng, Run and Xu, Chenxiao and Tian, Junrui and Peng, Qiu and Zheng, Xiang and Wang, Jia and Wei, Lingyu and Yan, Qun and Ma, Jian},
title = {Engineering a nano delivery system targets EphA2 for treating colorectal cancer oxaliplatin resistant},
journal = {Materials & Design},
year = {2025},
volume = {260},
pages = {115016},
doi = {10.1016/j.matdes.2025.115016}
}
EUVIMED